China Media Group has led a $14.5m series B round through its Hongxin Capital unit, bringing Gaiya's total funding to more than $25m.

CHA Medical Center-backed Solidus Investment Company has returned for a $30m series B round in Orum Therapeutics, which is targeting cancer and rare diseases.

The AI-powered music software creator has sourced commitments from Sony, Shure, Warner Music Group and Slaight Communications in the series B round.

CreditEase and existing investor Santander InnoVentures both took part in the round, which valued the digital payment card developer at about $250m.

Orchestra BioMed has confirmed Temuro’s participation in a $34m series B1 round, a month after the corporate entered into a strategic agreement that had it invest $5m of equity.

HRnetGroup-backed recruitment platform Glints will use proceeds from the $6.8m round to expand into Vietnam and Hong Kong

RiskGenius, a developer of insurance language processing technology, has received new funding, with FM Global and Hearst both taking part.

Netcetera-backed sales and marketing software provider Cognism will use the proceeds to open regional offices in the US and Asia, having already attracted business in those markets.

Cancer treatment company Biontech raised $325m round backed by Fidelity. The company forms part of the hopeful oncology and cancer treatment subsector of life sciences which has seen much growth and in corporate backing in recent years.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.